Bio-Rad Laboratories (BIO) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $385.63, for a total…

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP Courtney Enloe sold 902 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $386.17, for a t…

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) COO Jonathan Divincenzo sold 919 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $390.47, f…

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $385.63, for a tota…

Fisher Asset Management LLC lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The…

HOLMDEL, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced its third q…

KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distr…

BIO-key entered gaming & hospitality market with contract from major U.S. casino resort to deploy PortalGuard® IAM platform and Identity-Bound Biometrics.…

Bio-Rad Laboratories, Inc. ( BIO ) 2026 UBS Global Healthcare Conference November 10, 2026 8:00 AM EST Company Participants Roop Lakkaraju - Executive VP & CFO Conference Call Participants Douglas Schenkel - UBS Investme…

Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Al…

Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.…

Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs Medicus Chief Medical Officer will Highlight Company's Focus on P…

Bio-Rad Laboratories NYSE: BIO reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset weakness in parts of it…

Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript…

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.26 per share a year ago.…

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter end…

MINNEAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarter…

Cipher, a Prosegur Company, and BIO-key (BKYI) Announce Technology Integration to Expand Identity Security Offering Internationally, Starting in Portugal.…

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. L…

RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentication solutions, toda…

ZBRA's revenue growth accelerated across end markets and geographies, while margins and earnings exceeded expectations. CRL's results reflected improving demand across biopharma and biotechnology customers. Bio-Rad's sha…

BIO-key (BKYI) secured another Middle East government contract (new customer) for its passwordless, biometric, identity & access management (IAM) solutions…

On October 16, 2026, Bio-Rad Laboratories Inc (BIO) shares fell by 3.0%, bringing the current price to $353.70. The stock has experienced a 52-week range of $23…

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of …
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.

